Vision Supreme 2
Natural health product licensed in Canada
- Other names
- Health First Vision Supreme 2
- Licence holder
- Health First Network
- NPN or DIN-HM
- 80090580
- Status
- Active licence
- Licence date
- 12 February 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 25 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vaccinium myrtillus Source : Fruit Extract : Matériel brut sec Extraction ratio : 100:1 Dry plant equivalent : 1,000 milligramme Potency : 25 % Anthocyanidins | 10 milligramme | Not calculated |
| Zinc Source : Citrate de zinc | 12.5 milligramme | 25,000 µg |
| Cuivre Source : Citrate de cuivre (II) | 1 milligramme | 2,000 µg |
Non-medicinal ingredients
Cellulose microcristalline, Hydroxypropyl méthylcellulose, Dioxyde de silicium colloïdal, Phosphate de dicalcium dihydraté, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 day |
Uses authorised in Canada
Helps in connective tissue formation. An antioxidant that helps fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by cell damage caused by) free radicals. Helps to prevent Vitamin E deficiency. Helps to produce and repair connective tissue. Antioxidant for the maintenance of eye health. Helps to maintain eyesight and support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density. Used in Herbal Medicine to help slow the progression of disorders of the eye, such as diabetic and hypertensive retinopathy, and macular degeneration.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have cancer, cardiovascular disease or diabetes. Consult a health care practitioner if symptoms worsen.
- Effets indésirables connus
Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family.
Source
Official Health Canada record, licence 80090580
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.